**Question:** All of the following statements about Pneumocystis Jiroveci are true except -

A. Pneumocystis Jiroveci is a fungus.
B. It causes pneumonia in immunocompetent individuals.
C. Treatment with trimethoprim-sulfamethoxazole is effective against Pneumocystis Jiroveci.
D. It is a virus.

**Core Concept:** Pneumocystis Jiroveci is a fungus that primarily affects immunocompromised hosts and is treated with trimethoprim-sulfamethoxazole.

**Why the Correct Answer is Right:** Pneumocystis Jiroveci is indeed a fungus, not a virus as stated in option D. It belongs to the Opisthorchis class, which is a type of fungus called "mycete" or "yeast-like fungus." This fungus can cause pneumonia, particularly in individuals with compromised immune systems, as they are unable to mount an effective immune response against the fungus.

**Why Each Wrong Option is Incorrect:**

A. Pneumocystis Jiroveci is not a fungus, but a yeast-like fungus. This is incorrect for options A and B that state it is a fungus or yeast.

B. Pneumocystis Jiroveci pneumonia (PJP) primarily affects immunocompromised hosts, making it a key factor in the pathogenesis of this infection. However, this option incorrectly claims that it causes pneumonia in immunocompetent individuals (healthy individuals with intact immune systems).

C. Trimethoprim-sulfamethoxazole is a widely used medication for the treatment of PJP, making it an incorrect statement. The correct treatment involves the use of pentamidine or flucytosine, while trimethoprim-sulfamethoxazole is used for the prophylaxis (prevention) of PJP in high-risk individuals.

D. The statement "It is a virus" is incorrect, as Pneumocystis Jiroveci is a fungus, not a virus.

**Clinical Pearls:**

Pneumocystis Jiroveci is a significant pathogen in immunocompromised patients, particularly those with HIV/AIDS. This fungus is opportunistic, meaning it takes advantage of an impaired immune system to cause disease. Antifungal agents like pentamidine or flucytosine are used for treatment, while trimethoprim-sulfamethoxazole is used for prophylaxis (prevention) in high-risk individuals. Understanding the correct classification of Pneumocystis Jiroveci as a fungus is crucial for accurate diagnosis and treatment decisions.